Comparison of Imipenem and Ceftazidime as Therapy for Severe Melioidosis

Andrew J. H. Simpson(University of Hull), Nicholas J. White(Angkor Hospital for Children), Paul A. Howe(University of Liverpool), Yupin Suputtamongkol(Mahidol University), Amanda L. Walsh(University of Liverpool), Wipada Chaowagul(Sappasithiprasong Hospital), Vanaporn Wuthiekanun(Mahidol University), Adul Rajanuwong(University of Liverpool), Michael D. Smith(University of Liverpool), Brian Angus(University of Oxford)
Clinical Infectious Diseases
August 1, 1999
10.1086/520219
Cited by 199

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18
|Nature|2001|1.3k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
Typhoid Fever
|New England Journal of Medicine|2002|1.1k